FDA Strengthens Warning on Invokana Labeling
The U.S. Food and Drug Administration (FDA) recently revised its May 2015 warning to now include an increased risk of bone fractures and decreased bone mineral density. Bone mineral density relates to the strength of a person’s bones. The original FDA warning stated that SGLT2…